Skip to main content
logo
Mereo BioPharma Group plc (AIM:MPH)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
26.50
-0.50 (-1.85%)
Inactive · Last trade price on Dec 17, 2020

Mereo BioPharma Group Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '20 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
464943325473128
Market Cap Growth
-81.06%-88.62%70.57%249.41%-43.41%-27.46%
Enterprise Value
24133742211437

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '20 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----10.09
PS Ratio
-132.62-32.34-3.52
PB Ratio
2.121.628.896.401.701.46
P/TBV Ratio
2.141.648.996.541.702.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '20 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-36.02-28.17-1.02

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '20 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.110.120.300.19
Net Debt / Equity Ratio
-1.01-1.00-1.04-1.02-1.03-0.88
Net Debt / EBITDA Ratio
0.901.081.401.941.013.72
Net Debt / FCF Ratio
1.151.321.932.441.0813.43
Asset Turnover
-0.01-0.14-0.39
Quick Ratio
5.649.995.286.452.897.66
Current Ratio
5.8810.475.406.723.097.92
Return on Equity (ROE)
-67.85%-82.21%-77.58%-57.81%-53.63%34.85%
Return on Assets (ROA)
-42.46%-39.10%-39.99%-23.57%-28.67%-13.82%
Return on Invested Capital (ROIC)
-----825.95%-57.30%
Return on Capital Employed (ROCE)
-113.90%-91.90%-73.10%-47.60%-99.40%-18.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '20 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.20%-63.15%-7.98%-9.11%-48.22%9.91%
FCF Yield
-41.67%-46.74%-6.06%-6.54%-55.78%-4.50%
Buyback Yield / Dilution
-2.30%-7.77%-12.16%-9.33%-8.63%-63.82%